Why the study?
Many women with rheumatic diseases become pregnant and some undergo pregnancy termination, but official guidelines on pregnancy termination in this population are lacking.
Highlights the need for official guidelines and comprehensive counseling regarding pregnancy termination and planning for women with rheumatic diseases.
Answers are grounded in this paper and cite their sources.
Highlights need for individualized pregnancy planning in rheumatic diseases; leaves open official guidelines and targeted studies.
Rheumatic diseases affect women during their reproductive years. Many women with rheumatic diseases become pregnant; some undergo pregnancy termination. However, there are no official guidelines on pregnancy termination in patients with rheumatic diseases. This work provides an overview of factors that health care professionals must consider. We highlight areas that require further studies and the importance of pregnancy planning and contraception counseling. Patients with rheumatic diseases need to be informed of adverse maternal and fetal outcomes of pregnancy to make informed reproductive decisions and reduce the need for pregnancy terminations.
No takes yet. Share an insight, caveat, or question.
Mo et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: